US 8512712
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
granted A61KA61K35/28A61K35/765
Quick answer
US patent 8512712 (Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions) held by ONCOLYTICS BIOTECH INC. expires Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ONCOLYTICS BIOTECH INC.
- Grant date
- Tue Aug 20 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 15 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K35/28, A61K35/765, A61K48/00, A61P